Become A Featured Company

Trulieve Announces Filing of Final Base Shelf Prospectus

Ryan Allway

May 16th, 2019

News

TALLAHASSEE, FL, May 15, 2019 /CNW/ – National cannabis company Trulieve Cannabis Corp. (“Trulieve” ‎or the “Company“) (CSE: TRUL) announced that it has filed a (final) short form base ‎shelf prospectus with the securities regulatory authorities in each of the provinces of ‎Canada, other than the Province of Quebec.‎

The shelf prospectus is valid for a 25-month period, during which time Trulieve and certain of its security holders may qualify the distribution by way ‎of prospectus in Canada of up to $250 million of subordinate voting shares, debt securities, ‎warrants, subscription receipts, units, or any combination thereof of the Company from time to time, separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of the offering.  The specific terms of any future offering will be established in a prospectus supplement to the shelf prospectus, which supplement will be filed with the applicable Canadian securities regulatory authorities. Unless otherwise specified in the prospectus supplement relating to a particular offering of securities, the net proceeds from any sale of any securities may be used by Trulieve for general corporate purposes, including funding ongoing operations and/or working capital requirements, to repay ‎indebtedness outstanding from time to time, for capital projects and potential future acquisitions. The Company will ‎not receive any proceeds from any sale of any Securities by the selling securityholders.

A copy of the (final) short form base shelf prospectus can be found on SEDAR at www.sedar.com.

About Trulieve
Trulieve Cannabis Corp. is a vertically integrated “seed to sale” company and is the first and ‎largest fully licensed cannabis company in the State of Florida. Trulieve cultivates and ‎produces all of its products in-house and distributes those products to Trulieve-branded ‎stores (dispensaries) throughout the State of Florida, as well as directly to patients via ‎home delivery. Trulieve also operates in California and Massachusetts.‎

Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL.‎

This press release does not constitute an offer to sell or a solicitation of an offer to buy nor ‎shall there be any sale of any of the securities in any jurisdiction in which such offer, ‎solicitation or sale would be unlawful. The securities have not been and will not be ‎registered under the United States Securities Act of 1933, as amended (the “U.S. Securities ‎Act“), or the securities laws of any state of the United States and may not be offered or sold ‎within the United States (as defined in Regulation S under the U.S. Securities Act) unless ‎registered under the U.S. Securities Act and applicable state securities laws or pursuant to ‎an exemption from such registration requirements.‎

Regarding Forward-Looking Information
This press release may contain forward-looking information that is based on certain ‎assumptions and involves known and unknown risks and uncertainties and other factors ‎that could cause actual events to differ materially from current assumptions and ‎expectations. These statements should not be read as guarantees of future performance or ‎results. Such statements involve known and unknown risks, uncertainties and other factors ‎that may cause actual results, performance or achievements to be materially different from ‎those implied by such statements. A more complete discussion of the risks and ‎uncertainties facing the Company appears in the Company’s Annual Information Form and ‎continuous disclosure filings, which are available on SEDAR’s website at www.sedar.com. ‎Readers are cautioned not to place undue reliance on these forward-looking statements, ‎which speak only as of the date of this press release. The Company disclaims any intention ‎or  obligation, except to the extent required by law, to update or revise any forward-looking ‎statements as a result of new information or future events, or for any other reason.‎

SOURCE Trulieve Cannabis Corp.

For further information: Lynn Ricci, Director, Investor Relations, ‎(850) 270-5691, IR@trulieve.com; Victoria Walker, Director of Marketing & Community Relations, (704) 773-3446‎, Victoria.Walker@trulieve.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading